iRhythm Holdings (IRTC) Cash from Investing Activities (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 161.92% |
| Dec 31, 2025 | 45.30% |
| Sep 30, 2025 | 11.60% |
| Jun 30, 2025 | -164.60% |
| Mar 31, 2025 | 68.78% |
| Dec 31, 2024 | -120.77% |
| Sep 30, 2024 | -481.30% |
| Jun 30, 2024 | -63.72% |
| Mar 31, 2024 | 2,757.00% |
| Dec 31, 2023 | 109.07% |
| Sep 30, 2023 | -271.36% |
| Jun 30, 2023 | 135.84% |
| Mar 31, 2023 | 147.08% |
| Dec 31, 2022 | 77.05% |
| Sep 30, 2022 | -8,104.64% |
| Jun 30, 2022 | 94.95% |
| Mar 31, 2022 | 68.57% |
| Dec 31, 2021 | -298.63% |
| Sep 30, 2021 | 702.59% |
| Jun 30, 2021 | -98.55% |
| Mar 31, 2021 | 769.35% |
| Dec 31, 2020 | 91.45% |
| Sep 30, 2020 | -789.32% |
| Jun 30, 2020 | -50.49% |
| Mar 31, 2020 | 578.98% |
| Dec 31, 2019 | 85.63% |
| Sep 30, 2019 | -441.37% |
| Jun 30, 2019 | -160.97% |
| Mar 31, 2019 | 514.32% |
| Dec 31, 2018 | 154.69% |
| Sep 30, 2018 | -74.85% |
| Jun 30, 2018 | -68.76% |
| Mar 31, 2018 | 304.92% |
| Dec 31, 2017 | -270.50% |
| Sep 30, 2017 | 1,033.43% |
| Jun 30, 2017 | 97.78% |
| Mar 31, 2017 | 55.24% |
| Dec 31, 2016 | -8,722.47% |
| Sep 30, 2016 | -83.41% |
| Jun 30, 2016 | 37.78% |
| Mar 31, 2016 | -149.62% |